Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently.

Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

Combination of two compounds shows promise in the lab

Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.

The Chief Information Officer of the Novartis Institutes for BioMedical Research discusses his new role.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

Zebrafish imaging sheds light on human neurological conditions.

Researchers improve our understanding about how compounds bind to proteins in the cell membrane—and the membrane itself.